Skip to main content
TipRanks
Go Ultimate75% OFF

HCW Biologics (HCWB) Financial Statements

264 Followers

HCW Biologics Financial Overview

HCW Biologics's market cap is currently $1.79M. The company's EPS TTM is $-44.88; its P/E ratio is -0.02; HCW Biologics is estimated to report earnings on March 31, 2027, and the estimated EPS forecast is $-1.39. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 54.23K$ 2.57M$ 2.84M$ 6.72M$ 0.00
Gross Profit$ 10.85K$ 959.40K$ 560.36K$ 2.59M$ 0.00
Operating Income$ -11.26M$ -29.48M$ -25.72M$ -15.08M$ -13.37M
EBITDA$ -5.67M$ -27.68M$ -23.58M$ -14.06M$ -12.32M
Net Income$ -7.96M$ -30.02M$ -24.99M$ -14.90M$ -12.86M
Balance Sheet
Cash & Short-Term Investments$ 1.95M$ 4.67M$ 3.60M$ 32.06M$ 36.71M
Total Assets$ 24.52M$ 30.24M$ 28.51M$ 46.81M$ 53.51M
Total Debt$ 6.81M$ 13.69M$ 6.30M$ 6.41M$ 0.00
Net Debt$ 4.86M$ 9.02M$ 2.71M$ -15.92M$ -11.73M
Total Liabilities$ 21.76M$ 37.01M$ 15.05M$ 9.38M$ 2.32M
Stockholders' Equity$ 2.76M$ -6.77M$ 13.46M$ 37.43M$ 51.19M
Cash Flow
Free Cash Flow$ -13.39M$ -14.49M$ -28.72M$ -20.66M$ -11.02M
Operating Cash Flow$ -13.39M$ -14.23M$ -22.51M$ -10.39M$ -10.98M
Investing Cash Flow$ 0.00$ -261.62K$ 3.80M$ 14.71M$ -35.02M
Financing Cash Flow$ 10.67M$ 15.57M$ -14.53K$ 6.27M$ 49.27M

Currency in USD

HCW Biologics Earnings and Revenue History

-40M-20M020M-18000 %-12000 %-6000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

HCW Biologics Liabilities to Assets

020M40M60M0 %50 %100 %150 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

HCW Biologics Cash Flow

-40M-20M020M40M60M2019202020212022202320242025OperatingInvestingFinancing

HCW Biologics Forecast EPS vs Actual EPS

-30-20-1001020Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss